SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-091201
Filing Date
2022-08-15
Accepted
2022-08-15 16:06:59
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q rnaz-20220630x10q.htm   iXBRL 10-Q 1134675
2 EXHIBIT 31.1 rnaz-20220630xex31d1.htm EX-31.1 14085
3 EXHIBIT 31.2 rnaz-20220630xex31d2.htm EX-31.2 15115
4 EXHIBIT 32.1 rnaz-20220630xex32d1.htm EX-32.1 6326
5 EXHIBIT 32.2 rnaz-20220630xex32d2.htm EX-32.2 6284
  Complete submission text file 0001104659-22-091201.txt   4940212

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20220630.xsd EX-101.SCH 49776
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnaz-20220630_cal.xml EX-101.CAL 32223
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnaz-20220630_def.xml EX-101.DEF 124098
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20220630_lab.xml EX-101.LAB 378013
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20220630_pre.xml EX-101.PRE 272158
65 EXTRACTED XBRL INSTANCE DOCUMENT rnaz-20220630x10q_htm.xml XML 672379
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40363 | Film No.: 221165660
SIC: 2834 Pharmaceutical Preparations